✦ LIBER ✦

Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders

✍ Scribed by Radek Skoda

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acquired mutation of the tyrosine kinase

✍ E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 258 KB

Widespread occurrence of the JAK2 V617F

✍ Jones, A. V. 📂 Article 📅 2005 🏛 American Society of Hematology 🌐 English ⚖ 324 KB

The JAK2V617Fmutation: no impact on circ

✍ Michaela Wappl; Eva Jaeger; Raiko Kusec; Ilse Schwarzinger; Klaus Geissler; Leop 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 82 KB

Prevalence of the JAK2-V617F mutation in

✍ C.-H. Lieu; H.-S. Wu; Y.-C. Hon; W.-H. Tsai; C.-F. Yang; C.-C. Wang; Y.-C. Lin; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

The first international meeting on V617F

✍ J.J. Kiladjian; N. Casadevall; W. Vainchenker; P. Fenaux 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Role of the JAK2 mutation in the diagnos

✍ Massimo Primignani; Giovanni Barosi; Gaetano Bergamaschi; Umberto Gianelli; Fede 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB